183 related articles for article (PubMed ID: 20236528)
1. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
[TBL] [Abstract][Full Text] [Related]
2. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
Weil GJ; Kastens W; Susapu M; Laney SJ; Williams SA; King CL; Kazura JW; Bockarie MJ
PLoS Negl Trop Dis; 2008; 2(12):e344. PubMed ID: 19065257
[TBL] [Abstract][Full Text] [Related]
3. Evaluating elimination thresholds and stopping criteria for interventions against the vector-borne macroparasitic disease, lymphatic filariasis, using mathematical modelling.
Sharma S; Smith ME; Bilal S; Michael E
Commun Biol; 2023 Feb; 6(1):225. PubMed ID: 36849730
[TBL] [Abstract][Full Text] [Related]
4. Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
Antony Oliver MC; Graham M; Gass KM; Medley GF; Clark J; Davis EL; Reimer LJ; King JD; Pouwels KB; Hollingsworth TD
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S160-S168. PubMed ID: 38662697
[TBL] [Abstract][Full Text] [Related]
5. Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.
Irvine MA; Reimer LJ; Njenga SM; Gunawardena S; Kelly-Hope L; Bockarie M; Hollingsworth TD
Parasit Vectors; 2015 Oct; 8():547. PubMed ID: 26489753
[TBL] [Abstract][Full Text] [Related]
6. Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).
Collyer BS; Irvine MA; Hollingsworth TD; Bradley M; Anderson RM
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008644. PubMed ID: 33044958
[TBL] [Abstract][Full Text] [Related]
7. Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms.
Molyneux DH; Hopkins A; Bradley MH; Kelly-Hope LA
Parasit Vectors; 2014 Aug; 7():363. PubMed ID: 25128408
[TBL] [Abstract][Full Text] [Related]
8. Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy.
Prada JM; Touloupou P; Kebede B; Giorgi E; Sime H; Smith M; Kontoroupis P; Brown P; Cano J; Farkas H; Irvine M; Reimer L; Caja Rivera R; de Vlas SJ; Michael E; Stolk WA; Pulan R; Spencer SEF; Hollingsworth TD; Seife F
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S117-S125. PubMed ID: 38662702
[TBL] [Abstract][Full Text] [Related]
9. The argument for integrating vector control with multiple drug administration campaigns to ensure elimination of lymphatic filariasis.
Burkot TR; Durrheim DN; Melrose WD; Speare R; Ichimori K
Filaria J; 2006 Aug; 5():10. PubMed ID: 16914040
[TBL] [Abstract][Full Text] [Related]
10. A game-theoretic model of lymphatic filariasis prevention.
Rychtář J; Taylor D
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010765. PubMed ID: 36137005
[TBL] [Abstract][Full Text] [Related]
11. Elimination of lymphatic filariasis: current perspectives on mass drug administration.
Gyapong JO; Owusu IO; da-Costa Vroom FB; Mensah EO; Gyapong M
Res Rep Trop Med; 2018; 9():25-33. PubMed ID: 30050352
[TBL] [Abstract][Full Text] [Related]
12. Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling.
Slater H; Michael E
PLoS One; 2012; 7(2):e32202. PubMed ID: 22359670
[TBL] [Abstract][Full Text] [Related]
13. Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold.
Prada JM; Davis EL; Touloupou P; Stolk WA; Kontoroupis P; Smith ME; Sharma S; Michael E; de Vlas SJ; Hollingsworth TD
J Infect Dis; 2020 Jun; 221(Suppl 5):S503-S509. PubMed ID: 31853554
[TBL] [Abstract][Full Text] [Related]
14. Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria.
Eneanya OA; Reimer LJ; Fischer PU; Weil GJ
Int Health; 2023 Sep; 15(5):566-572. PubMed ID: 37096453
[TBL] [Abstract][Full Text] [Related]
15.
Quek S; Cook DAN; Wu Y; Marriott AE; Steven A; Johnston KL; Ford L; Archer J; Hemingway J; Ward SA; Wagstaff SC; Turner JD; Taylor MJ
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120003119. PubMed ID: 35377795
[TBL] [Abstract][Full Text] [Related]
16. Assessing the effects of disease-specific programs on health systems: An analysis of the Bangladesh Lymphatic Filariasis Elimination Program's impacts on health service coverage and catastrophic health expenditure.
Koporc KM; Hotchkiss DR; Stoecker CF; McFarland DA; Carton T
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009894. PubMed ID: 34813600
[TBL] [Abstract][Full Text] [Related]
17. Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa.
Touloupou P; Retkute R; Hollingsworth TD; Spencer SEF
Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100391. PubMed ID: 35691660
[TBL] [Abstract][Full Text] [Related]
18. Environmental suitability for lymphatic filariasis in Nigeria.
Eneanya OA; Cano J; Dorigatti I; Anagbogu I; Okoronkwo C; Garske T; Donnelly CA
Parasit Vectors; 2018 Sep; 11(1):513. PubMed ID: 30223860
[TBL] [Abstract][Full Text] [Related]
19. Global elimination of lymphatic filariasis: a "mass uprising of compassion".
Addiss DG
PLoS Negl Trop Dis; 2013; 7(8):e2264. PubMed ID: 24009784
[No Abstract] [Full Text] [Related]
20. Genomic Epidemiology in Filarial Nematodes: Transforming the Basis for Elimination Program Decisions.
Hedtke SM; Kuesel AC; Crawford KE; Graves PM; Boussinesq M; Lau CL; Boakye DA; Grant WN
Front Genet; 2019; 10():1282. PubMed ID: 31998356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
